Resting heart rate and the risk of type 2 diabetes: A systematic review and doseeresponse meta-analysis of cohort studies

被引:57
作者
Aune, D. [1 ,2 ]
Hartaigh, B. O. [3 ,4 ]
Vatten, L. J. [1 ]
机构
[1] Norwegian Univ Sci & Technol, Fac Med, Dept Publ Hlth & Gen Practice, N-7034 Trondheim, Norway
[2] Univ London Imperial Coll Sci Technol & Med, Dept Epidemiol & Biostat, Sch Publ Hlth, London W2 1PG, England
[3] Weill Cornell Med Coll, Dalio Inst Cardiovasc Imaging, New York, NY USA
[4] Yale Univ, Sch Med, Dept Internal Med, Sect Geriatr, New Haven, CT 06510 USA
关键词
Resting heart rate; Type; 2; diabetes; Systematic review; Meta-analysis; SYMPATHETIC-NERVOUS-SYSTEM; INDUCED INSULIN-RESISTANCE; MIDDLE-AGED MEN; CARDIOVASCULAR MORBIDITY; HYPERTENSIVE PATIENTS; AUTONOMIC FUNCTION; BLOOD-PRESSURE; MORTALITY; MELLITUS; OBESITY;
D O I
10.1016/j.numecd.2015.02.008
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: High resting heart rate has been associated with increased risk of type 2 diabetes in several studies, but the available data are not consistent and it is unclear if there is a doseeresponse relationship between resting heart rate and type 2 diabetes risk. We aimed to clarify this association by conducting a systematic review and meta-analysis of published studies. Methods and results: PubMed, Embase and Ovid Medline databases were searched for prospective studies published up until October 11th, 2013. Summary relative risks were estimated using a random effects model. Ten cohort studies with >5628 cases and 119,915 participants were included. The summary RR for high vs. low resting heart rate was 1.83 (95% CI: 1.28 -2.60, I-2 = 88%, n = 7), and in the doseeresponse analysis the summary RR was 1.20 (95% CI: 1.07-1.34, I-2 = 93%, n = 9) for an increase of 10 beats per minute. The heterogeneity was to a large degree explained by two studies. There was evidence of nonlinear associations between resting heart rate (p(nonlinearity) < 0.0001) and risk of type 2 diabetes. Conclusion: The current meta-analysis indicates a strong positive association between high resting heart rate and the risk of type 2 diabetes. As a non-invasive marker of type 2 diabetes risk, resting heart rate may have potential in the clinical setting, especially for interventions aimed at lowering the risk of type 2 diabetes. Additional studies are needed to clarify the mechanisms that may be responsible for the assoiation between resting heart rate and type 2 diabetes. (C) 2015 Elsevier B.V. All rights reserved.
引用
收藏
页码:526 / 534
页数:9
相关论文
共 44 条
[1]   Predictors of new-onset diabetes mellitus in hypertensive patients:: the VALUE trial [J].
Aksnes, T. A. ;
Kjeldsen, S. E. ;
Rostrup, M. ;
Stoerset, O. ;
Hua, T. A. ;
Julius, S. .
JOURNAL OF HUMAN HYPERTENSION, 2008, 22 (08) :520-527
[2]   Risk of elevated resting heart rate on the development of type 2 diabetes in patients with clinically manifest vascular diseases [J].
Bemelmans, Remy H. H. ;
Wassink, Annemarie M. J. ;
van der Graaf, Yolanda ;
Nathoe, Hendrik M. ;
Vernooij, Joris W. P. ;
Spiering, Wilko ;
Visseren, Frank L. J. .
EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2012, 166 (04) :717-725
[3]  
Bosch J, 2006, NEW ENGL J MED, V355, P1551
[4]   Resting Heart Rate in Middle Age and Diabetes Development in Older Age [J].
Carnethon, Mercedes R. ;
Yan, Lijing ;
Greenland, Philip ;
Garside, Daniel B. ;
Dyer, Alan R. ;
Metzger, Boyd ;
Daviglus, Martha L. .
DIABETES CARE, 2008, 31 (02) :335-339
[5]   The association among autonomic nervous system function, incident diabetes, and intervention arm in the diabetes prevention program [J].
Carnethon, MR ;
Prineas, RJ ;
Temprosa, M ;
Zhang, ZM ;
Uwaifo, G ;
Molitch, ME .
DIABETES CARE, 2006, 29 (04) :914-919
[6]   Prospective investigation of autonomic nervous system function and the development of type 2 diabetes - The Atherosclerosis Risk in Communities study, 1987-1998 [J].
Carnethon, MR ;
Golden, SH ;
Folsom, AR ;
Haskell, W ;
Liao, DP .
CIRCULATION, 2003, 107 (17) :2190-2195
[7]   Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE):: a randomised trial against atenolol [J].
Dahlöf, B ;
Devereux, RB ;
Kjeldsen, SE ;
Julius, S ;
Beevers, G ;
de Faire, U ;
Fyhrquist, F ;
Ibsen, H ;
Kristiansson, K ;
Lederballe-Pedersen, O ;
Lindholm, LH ;
Nieminen, MS ;
Omvik, P ;
Oparil, S ;
Wedel, H .
LANCET, 2002, 359 (9311) :995-1003
[8]   EPINEPHRINE-INDUCED INSULIN RESISTANCE IN MAN [J].
DEIBERT, DC ;
DEFRONZO, RA .
JOURNAL OF CLINICAL INVESTIGATION, 1980, 65 (03) :717-721
[9]   METAANALYSIS IN CLINICAL-TRIALS [J].
DERSIMONIAN, R ;
LAIRD, N .
CONTROLLED CLINICAL TRIALS, 1986, 7 (03) :177-188
[10]   Bias in meta-analysis detected by a simple, graphical test [J].
Egger, M ;
Smith, GD ;
Schneider, M ;
Minder, C .
BMJ-BRITISH MEDICAL JOURNAL, 1997, 315 (7109) :629-634